Strimvelis<sup>®</sup> for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation.

South, Emily; Cox, Edward; Meader, Nick; Woolacott, Nerys; Griffin, Susan

Strimvelis^® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation.

South, Emily; Cox, Edward; Meader, Nick; Woolacott, Nerys; Griffin, Susan.

Afiliación

South E; Centre for Reviews and Dissemination, University of York, York, YO10 5DD, UK. emily.south@york.ac.uk.
Cox E; Centre for Health Economics, University of York, York, UK.
Meader N; Centre for Reviews and Dissemination, University of York, York, YO10 5DD, UK.
Woolacott N; Centre for Reviews and Dissemination, University of York, York, YO10 5DD, UK.
Griffin S; Centre for Health Economics, University of York, York, UK.

Pharmacoecon Open ; 3(2): 151-161, 2019 Jun.

Article en En | MEDLINE | ID: mdl-30334168

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_geracao_evidencia_conhecimento / 2_cobertura_universal Tipo de estudio: Guideline / Health_technology_assessment / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Pharmacoecon Open Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google